GSC The List

Post Reply

[email protected]
Site Owner
Posts: 1174

Endocannabinoids and fatty acid amides in cancer, inflammation and related disorders. (abst – 2000)

Antiinflammatory action of endocannabinoid palmitoylethanolamide and the synthetic cannabinoid nabilone in a model of acute inflammation in the rat (full - 2002)

Inhibition of Inflammatory Hyperalgesia by Activation of Peripheral CB2 Cannabinoid Receptors (full – 2003)

Cannabidiol-transdermal delivery and anti-inflammatory effect in a murine model. (abst - 2003)

Cannabinoids spell relief in colon inflammation (news – 2004)

New perspectives in the studies on endocannabinoid and cannabis: 2-arachidonoylglycerol as a possible novel mediator of inflammation (full - 2004)

Cannabinoids and neuroinflammation (full - 2004)

Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. (full - 2004)

A novel synthetic, nonpsychoactive cannabinoid acid (HU-320) with antiinflammatory properties in murine collagen-induced arthritis. (full - 2004)

The cannabinoid receptor agonist WIN 55212-2 inhibits neurogenic inflammations in airway tissues. (full – 2005)

Ajulemic acid (IP-751): Synthesis, proof of principle, toxicity studies, and clinical trials (full - 2005)

Stimulation of cannabinoid receptor 2 (CB2) suppresses microglial activation (link to PDF– 2005)

Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: relevance to Parkinson's disease. (abst - 2005)

Endogenous cannabinoid receptor agonists inhibit neurogenic inflammations in guinea pig airways. (abst – 2005)

Role of the Cannabinoid System in Pain Control and Therapeutic Implications for the Management of Acute and Chronic Pain Episodes (full - 2006)

Involvement of the Cannabinoid CB2 Receptor and Its Endogenous Ligand 2-Arachidonoylglycerol in Oxazolone-Induced Contact Dermatitis in Mice (full – 2006)

The endocannabinoid anandamide protects neurons during CNS inflammation by induction of MKP-1 in microglial cells. (abst – 2006)

Cannabinoid-Induced Immune Suppression and Modulation of Antigen-Presenting Cells (abst – 2006)

Endocannabinoid metabolism and uptake: novel targets for neuropathic and inflammatory pain (full - 2007)

Cannabinoid-2 receptor agonist HU-308 protects against hepatic ischemia/reperfusion injury by attenuating oxidative stress, inflammatory response, and apoptosis (full - 2007)

Cannabidiol in vivo blunts β-amyloid induced neuroinflammation by suppressing IL-1β and iNOS expression (Alzheimer's) (full - 2007)

Opposing control of cannabinoid receptor stimulation on amyloid-beta-induced reactive gliosis: in vitro and in vivo evidence. (full - 2007)

Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro (full - 2007)

Honokiol, a natural plant product, inhibits inflammatory signals and alleviates inflammatory arthritis. (full – 2007)

Anti-inflammatory property of the cannabinoid agonist WIN-55212-2 in a rodent model of chronic brain inflammation (full - 2007)

Anti-inflammatory property of the cannabinoid receptor-2-selective agonist JWH-133 in a rodent model of autoimmune uveoretinitis (full - 2007)

The endocannabinoid system in targeting inflammatory neurodegenerative diseases (full - 2007)

Actions of N-arachidonyl-glycine in a rat inflammatory pain model. (full – 2007)

Cannabinoid CB2 receptors: a therapeutic target for the treatment of inflammatory and neuropathic pain (full - 2007)

Endocannabinoids, cannabinoid receptors and inflammatory stress: an interview with Dr. Pál Pacher (interview - 2007)

Cannabinoids and neuroprotection in motor-related disorders. (abst - 2007)

Cannabis tinctures and extracts – in vitro profiling for cytotoxic and anti-inflammatory effects (abst – 2007)

Cannabinoids for the treatment of inflammation. (abst - 2007)

A cannabinoid agonist differentially attenuates deep tissue hyperalgesia in animal models of cancer and inflammatory muscle pain. (abst – 2007)

Constituents Of Hashish And Marijuana May Help To Fight Inflammation And Allergies (news - 2007)

Pot Chemical May Curb Inflammation (news – 2007)

Endocannabinoids appear to play important role in regulating inflammation (news - 2007)

Hippies vindicated: Human-produced cannabinoids have anti-inflammatory powers (news – 2007)

Anti-inflammatory cannabinoids in diet (full - 2008)

Cannabinoid receptors in acute and chronic complications of atherosclerosis (full - 2008)

Cannabinoid receptor stimulation is anti-inflammatory and improves memory in old rats. (full - 2008)

Inflammation and aging: can endocannabinoids help? (full - 2008)

Cannabinoid CB2 receptors in human brain inflammation (full - 2008)

Cannabinoid Modulation of Cutaneous A{delta} Nociceptors During Inflammation (full - 2008)

Cannabinoid modulation of cutaneous Adelta nociceptors during inflammation. (full – 2008)

Inhibition of human neutrophil chemotaxis by endogenous cannabinoids and phytocannabinoids: evidence for a site distinct from CB1 and CB2. (full – 2008)

Cannabidiol in medicine: a review of its therapeutic potential in CNS disorders. (abst - 2008)

Ajulemic acid, a synthetic cannabinoid acid, induces an antiinflammatory profile of eicosanoids in human synovial cells. (abst – 2008)

Discovery of a novel cannabinoid in food (abst – 2008)

Scientists are High on Idea that Cannabis Reduces Memory Impairment (news - 2008)

Why Cannabis Stems Inflammation (news - 2008)

Emerging Role of the CB2 Cannabinoid Receptor in Immune Regulation and Therapeutic Prospects (full - 2009)

The endocannabinoid system of the skin in health and disease: novel perspectives and therapeutic opportunities (full – 2009)

Cannabinoid CB2 Receptor Potentiates Obesity-Associated Inflammation, Insulin Resistance and Hepatic Steatosis (full - 2009)

Cannabinoids Δ9-Tetrahydrocannabinol and Cannabidiol Differentially Inhibit the Lipopolysaccharide-activated NF-κB and Interferon-β/STAT Proinflammatory Pathways in BV-2 Microglial Cells (full – 2009)

Ajulemic acid, a synthetic cannabinoid, increases formation of the endogenous proresolving and anti-inflammatory eicosanoid, lipoxin A4 (full - 2009)

Cannabinoids as Therapeutic Agents for Ablating Neuroinflammatory Disease (full - 2009)

Endocannabinoids may mediate the ability of (n-3) fatty acids to reduce ectopic fat and inflammatory mediators in obese Zucker rats. (full – 2009)

Cannabidiol Attenuates Cisplatin-Induced Nephrotoxicity by Decreasing Oxidative/Nitrosative Stress, Inflammation, and Cell Death (full – 2009)

Cannabinoids as novel anti-inflammatory drugs. (full - 2009)

Cannabinoids, Endocannabinoids, and Related Analogs in Inflammation (full - 2009)

Endocannabinoid signalling as an anti-inflammatory therapeutic target in atherosclerosis: does it work? (full – 2009)

Pretreatment with electroacupuncture induces rapid tolerance to focal cerebral ischemia through regulation of endocannabinoid system. (full – 2009)

The nonpsychotropic cannabinoid cannabidiol modulates and directly activates alpha-1 and alpha-1-Beta glycine receptor function (abst – 2009)

Cannabidiol decreases bone resorption by inhibiting RANK/RANKL expression and proinflammatory cytokines during experimental periodontitis in rats. (abst - 2009)

Cannabinoids attenuate the effects of aging upon neuroinflammation and neurogenesis. (abst – 2009)

Endogenous anandamide and cannabinoid receptor-2 contribute to electroacupuncture analgesia in rats. (abst – 2009)

Cannabinoids produced in the human body have an anti-inflammatory effect (news – 2009)

Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression. (full - 2010)

Cannabinoids and Viral Infections (full - 2010)

European Patent Application EP2044935- A composition containing non-psychotropic cannabinoids for the treatment of inflammatory diseases (full – 2010)

The endocannabinoid system as a target for the treatment of neurodegenerative disease (full - 2010)

The effects of Delta-tetrahydrocannabinol and cannabidiol alone and in combination on damage, inflammation and in vitro motility disturbances in rat colitis. (full - 2010)

Regulatory Role of Cannabinoid Receptor 1 in Stress-Induced Excitotoxicity and Neuroinflammation (full - 2010)

Synthesis of Novel Cannabinoid Ligands and Their Use as Anti-Glioma and Anti-Inflammatory Agents (full – 2010)

N-arachidonoyl glycine, an abundant endogenous lipid, potently drives directed cellular migration through GPR18, the putative abnormal cannabidiol receptor (full – 2010)

Acute administration of cannabidiol in vivo suppresses ischaemia-induced cardiac arrhythmias and reduces infarct size when given at reperfusion. (full – 2010)

Naphthalen-1-yl-(4-pentyloxynaphthalen-1-yl)methanone (SAB378), a peripherally restricted cannabinoid CB1/CB2 receptor agonist, inhibits gastrointestinal motility but has no effect on experimental colitis in mice. (full – 2010)

WIN55212-2 ameliorates atherosclerosis associated with suppression of proinflammatory responses in ApoE-knockout mice. (abst – 2010)

Beneficial effects of cannabinoids (CB) in a murine model of allergen-induced airway inflammation: Role of CB(1)/CB(2) receptors. (abst - 2010)

Levels of endocannabinoids and palmitoylethanolamide and their pharmacological manipulation in chronic granulomatous inflammation in rats. (abst – 2010)

Light Marijuana Use Appears Protective Against Diabetes (news – 2010)[tt_news]=41212

Hemp Oil Benefits for Skin (news – 2010)

September 10, 2014 at 5:23 AM Flag Quote & Reply

You must login to post.